Roughly one in eight Americans is now taking a GLP-1 weight loss medication, and the effects are traveling far beyond individual health decisions into the structure of the food industry itself. GLP-1 users are driving household purchasing decisions, changing what families eat, when they eat and how much product is consumed per sitting. Retailers are adjusting product placement, manufacturers are reformulating core ingredients, and agribusiness is beginning to feel the shift farther up the supply chain. Protein and nutrient-dense categories are gaining ground, while empty-calorie staples face a demand environment that has structurally changed.
Ben Klieve is a Senior Equity Research Analyst at Benchmark, covering food and agribusiness equities across the full length of the food chain, from farm inputs and animal protein to novel ingredients, specialty crops and better-for-you consumer packaged goods companies. As a Chartered Financial Analyst with prior senior research roles at Lake Street Capital Markets, National Securities and Noble Capital Markets, his coverage tracks the categories where GLP-1 adoption is creating the most visible demand divergence, including protein segments, dairy markets and insurgent consumer brands gaining velocity at the expense of legacy incumbents.
Key Themes from the Discussion
Roughly one in eight Americans takes a GLP-1 drug, influencing household food choices beyond individual users.
Protein, dairy and fiber-rich whole grains are gaining shelf velocity as GLP-1 users seek nutrient-dense, smaller-portion options.
Liquid milk consumption is showing early signs of per capita recovery after roughly 60 years of structural decline.
Protein Categories Gain Ground as GLP-1 Adoption Accelerates
GLP-1 drugs reduce total consumption but not evenly across categories. Users gravitate toward protein, fiber, and foods that sustain satiety in smaller portions, and that shift is registering simultaneously across dairy, animal proteins, functional foods and probiotic-rich fermented offerings. "Animal proteins, dairy, functional foods, probiotic-rich food like kefir and other fermented offerings, whole grains that are fiber rich and nutrient dense. Those are the categories that benefit the most." Beverage formats and protein-dense snacking are also gaining ground, and GLP-1 users develop more sensitive palates that steer them toward milder flavors, creating a surprising tailwind for categories as unlikely as soup.
Legacy Food Brands Lose Ground to Protein-Forward Insurgents
The center of the store is where the competitive pressure is most acute. Legacy food companies that built dominant positions in cereals, baked goods, pasta and snacks are contending with challenger brands that are reformulating those same categories around protein content and fiber density. Klieve points to pasta and mac and cheese as examples where insurgent labels have developed a taste profile that now competes with established names while meeting the nutritional requirements GLP-1 users are seeking. "The brands that are really innovating to disrupt legacy categories are really the ones that are faring quite well."
Agribusiness Inputs Shift as Protein Demand Moves Up the Supply Chain
The structural change visible in the grocery aisle is moving up the food supply chain. Klieve sees GLP-1 adoption as cementing the position of animal agriculture after several years of pressure on that sector, with dairy standing out as the sharpest leading indicator. "Dairy demand is actually improving for the first time in like 60 years," he notes, adding that liquid milk consumption is showing early signs of per capita recovery in the U.S. after roughly six decades of structural decline. On the plant-based side, he identifies an emerging opportunity in non-traditional specialty grains and novel proteins, as consumer packaged goods companies seek to differentiate from legacy soy and corn-derived ingredients and meet growing consumer preference for more varied protein sources.
Make Markets Insights Your Competitive Advantage
Access live prices, supply and demand data and actionable market commentary. Sign up for StoneX Market Intelligence today and receive a 14-day trial.
--- Expert: Ben Klieve, Senior Equity Research Analyst, Benchmark
Meats & Livestock
The subsidiaries of StoneX Group Inc. provide financial products and services, including, but not limited to, physical commodities, securities, clearing, global payments, risk management, asset management, foreign exchange, and exchange-traded and over-the-counter derivatives. These financial products and services are offered in accordance with the applicable laws in the jurisdictions in which they are provided and are subject to specific terms, conditions, and restrictions contained in the terms of business applicable to each such offering. Not all products and services are available in all countries. The products and services offered by the StoneX Group of companies involve risk of loss and may not be suitable for all investors. Full Disclaimer. This content is not intended for residents of any particular country, and the information herein is not advice nor a recommendation to trade nor does it constitute an offer or solicitation to buy or sell any financial product or service, by any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation. Please refer to the Regulatory Disclosure section for entity-specific disclosures. No part of this material may be copied, photocopied or duplicated in any form by any means or redistributed without the prior written consent of StoneX Group Inc. The information herein is provided for informational purposes only. This information is provided on an ‘as-is’ basis and may contain statements and opinions of the StoneX Group of companies as well as excerpts and/or information from public sources and third parties and no warranty, whether express or implied, is given as to its completeness or accuracy. Each company within the StoneX Group of companies (on its own behalf and on behalf of its directors, employees and agents) disclaims any and all liability as well as any third-party claim that may arise from the accuracy and/or completeness of the information detailed herein, as well as the use of or reliance on this information by the recipient, any member of its group or any third party.
Our market expertise, advanced platforms, global reach, culture of full transparency and commitment to our clients’ success all set us apart in the financial marketplace.
Reach
With access to 40+ derivatives exchanges, 180+ foreign exchange markets, nearly every global securities marketplace and numerous bi-lateral liquidity venues, StoneX’s digital network and deep relationships can take clients anywhere they want to go.
Transparency
As a publicly traded company meeting the highest standards of regulatory compliance in the markets we serve; our financials and record of accomplishment are matters of public record. StoneX’s commitment to “doing the right thing over the easy thing” sets us apart in the industry and helps us build respect, client trust and new partnerships.
Expertise
From our proprietary Market Intelligence platform, to “boots on the ground” expertise from award-winning traders and professionals, we connect our clients directly to actionable insights they can use to make more informed decisions and achieve their goals in the global markets.
